These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29465367)

  • 1. Proprotein convertase enzyme FURIN is upregulated in primary Sjögren's syndrome.
    Ranta N; Valli A; Grönholm A; Silvennoinen O; Isomäki P; Pesu M; Pertovaara M
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):47-50. PubMed ID: 29465367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
    Liu TT; Zeng XP; Gu ML; Deng AM
    Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ICAM-1, VCAM-1 and E-selectin levels in patients with primary and secondary Sjögren's syndrome.
    Błochowiak KJ; Olewicz-Gawlik A; Trzybulska D; Nowak-Gabryel M; Kocięcki J; Witmanowski H; Sokalski J
    Adv Clin Exp Med; 2017 Aug; 26(5):835-842. PubMed ID: 29068581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
    Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
    Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of the proprotein convertase enzyme FURIN in rheumatoid arthritis.
    Valli A; Ranta N; Grönholm A; Silvennoinen O; Pesu M; Isomäki P
    Scand J Rheumatol; 2019 May; 48(3):173-177. PubMed ID: 30474480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
    Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
    Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
    Front Immunol; 2021; 12():673658. PubMed ID: 34012457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis?
    Alunno A; Caneparo V; Carubbi F; Bistoni O; Caterbi S; Bartoloni E; Giacomelli R; Gariglio M; Landolfo S; Gerli R
    Arthritis Res Ther; 2015 Aug; 17(1):208. PubMed ID: 26271464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of T-helper cells in patients with primary Sjogren's syndrome.
    Sudzius G; Mieliauskaite D; Butrimiene I; Siaurys A; Mackiewicz Z; Dumalakiene I
    In Vivo; 2013; 27(2):263-8. PubMed ID: 23422488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.
    Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W
    Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
    Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
    Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-146a and miR-155 expression in PBMCs from patients with Sjögren's syndrome.
    Shi H; Zheng LY; Zhang P; Yu CQ
    J Oral Pathol Med; 2014 Nov; 43(10):792-7. PubMed ID: 24931100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands.
    Alunno A; Caneparo V; Carubbi F; Bistoni O; Caterbi S; Gariglio M; Bartoloni E; Landolfo S; Gerli R
    Reumatismo; 2015 Dec; 67(3):85-90. PubMed ID: 26876186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
    Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
    Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.
    Mandal SK; Sandhya P; Kabeerdoss J; Ramya J; Mahasampath G; Danda D
    Rheumatol Int; 2018 May; 38(5):831-836. PubMed ID: 29541901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
    Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
    Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of increased TRAF6 expression in the peripheral mononuclear cells of patients with primary Sjögren's syndrome by an EBV-EBER1-specific synthetic single-stranded complementary DNA molecule.
    Sipka S; Zilahi E; Papp G; Chen JQ; Nagy A; Hegyi K; Kónya J; Zeher M
    Int J Rheum Dis; 2017 May; 20(5):614-621. PubMed ID: 28470929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.